Bank of America’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$245K Buy
63,147
+42,980
+213% +$106K ﹤0.01% 5251
2025
Q4
$39.3K Buy
20,167
+19,354
+2,381% +$31.7K ﹤0.01% 5905
2025
Q3
$686 Sell
813
-7,550
-90% -$5.55K ﹤0.01% 7538
2025
Q2
$6.05K Sell
8,363
-21,289
-72% -$16K ﹤0.01% 7269
2025
Q1
$25.5K Sell
29,652
-19,767
-40% -$29.4K ﹤0.01% 6906
2024
Q4
$83K Buy
49,419
+13,363
+37% +$32K ﹤0.01% 6473
2024
Q3
$103K Buy
36,056
+9,348
+35% +$24.2K ﹤0.01% 6311
2024
Q2
$62.5K Buy
26,708
+16,993
+175% +$44.4K ﹤0.01% 6441
2024
Q1
$28.6K Sell
9,715
-32,503
-77% -$92.2K ﹤0.01% 6679
2023
Q4
$126K Buy
42,218
+5,616
+15% +$16.1K ﹤0.01% 6282
2023
Q3
$116K Buy
36,602
+1,476
+4% +$4.8K ﹤0.01% 6189
2023
Q2
$136K Sell
35,126
-882
-2% -$2.54K ﹤0.01% 6068
2023
Q1
$99.7K Sell
36,008
-4,172
-10% -$8.75K ﹤0.01% 6262
2022
Q4
$72.3K Buy
40,180
+6,368
+19% +$12.3K ﹤0.01% 6360
2022
Q3
$72K Sell
33,812
-3,500
-9% -$8.8K ﹤0.01% 6508
2022
Q2
$101K Sell
37,312
-39,419
-51% -$147K ﹤0.01% 6458
2022
Q1
$333K Buy
76,731
+72,578
+1,748% +$298K ﹤0.01% 6106
2021
Q4
$22K Sell
4,153
-17,448
-81% -$93.4K ﹤0.01% 7486
2021
Q3
$133K Buy
21,601
+20,101
+1,340% +$160K ﹤0.01% 6558
2021
Q2
$15K Buy
+1,500
New +$16.2K ﹤0.01% 7217

Other funds holding NAUT

Bank of America's NAUT Position: Q1 2026 in Review

Bank of America increased its Nautilus Biotechnolgy (NAUT) stake by 213% in Q1 2026, buying an estimated $106K and bringing the position to 63,147 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #5251.

Bank of America first reported a position in NAUT in Q2 2021 and has held it in 20 quarters since. The position peaked at $333K in Q1 2022. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Bank of America held 63,147 shares of Nautilus Biotechnolgy worth $245K as of Q1 2026.
  • Bank of America bought 42,980 Nautilus Biotechnolgy shares in Q1 2026, an estimated $106K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5251 holding.
  • Bank of America first reported a position in Nautilus Biotechnolgy in Q2 2021 and has held it in 20 quarters since.
  • Bank of America's Nautilus Biotechnolgy position peaked at $333K in Q1 2022.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.